Kalp yetersizliği hastalarında glukoz-insülin-potasyum infüzyonunun p dalga dispersiyonu üzerine etkisi
Kalp yetersizliği seyrinde izlenilen atriyal fibrilasyon (AF) prognoz ve fonksiyonel kapasite üzerinde olumsuz etkilere neden olmaktadır. P dalga dispersiyonu AF gelişimini predikte eden önemli parametrelerden biri olarak kabul görmüştür. Glukoz-insülinpotasyum (GİK) infüzyonunun hemodinamik ve metabolik olumlu etkileri bilinmektedir. Çalışmamızda kalp yetersizliği olan hastalarda GİK infüzyonunun P dalga dispersiyonu üzerine olan etkisi araştırıldı. Çalışmamıza kalp yetersizliği ve düşük sol ventrikül ejeksiyon fraksiyonu (EF0.05) hesaplandı. Grup Ide GİK infüzyonu sonrasında ölçülen P dalga dispersiyonu 13±6.5 hesaplandı. Grup IIde ise verilen %0.9 NaCl solüsyonu sonrasında P dalga dispersiyonu 20.4±6.4 olarak hesaplandı. Her iki grubun çalışma sonrası hesaplanan P dalga dispersiyonunda önemli istatistiksel fark bulundu (p=0.001) ve GİK alan grupta P dalga dispersiyonu önemli ölçüde kısalmaktaydı. Çalışmamıza göre GİK infüzyonu alan hastalarda AFnin prediktör olan P dalga dispersiyonunun kontrol grubuna göre anlamlı olarak azaldığı gösterildi.
The effect of the glucose-insulin-potassium solution on the p-wave dispersion of the heart failure patients
Atrial fibrillation (AF) has adverse effects on the disease prognosis and the functional capacity during heart failure. P wave dispersion has been considered as one of the most important parameters predicting the development of AF. It is known that glucose-insulinpotassium (GIK) infusion has favorable metabolic and hemodynamic effects. The aim of our study is to investigate the effects of GIK infusion on P wave dispersion in patients with heart failure. In our study, 30 patients with the diagnosis of heart failure and a low left ventricular ejection fraction (EF0.05). In Group I, P wave dispersion measured after GIK infusion was 13 ± 6.5. In group II, P wave dispersion measured after 0.9% NaCl solution infusion were 20.4±6.4. P wave dispersion was found significantly lower in patients administrated GİK infusion (p=0.001). According to the present study, we showed that the P wave dispersion which predicts AF was significantly lower in the patients treated with GIK than in the control group.
___
- 1. Zipes DP. The seventh annual Gordan K. Moe lecture. Atrial
fibrillation: from cell to bedside. J Cardiovasc Electrophysiol
1997;8(8):927-38
- 2. Perzanowski C, Ho AT, Jacobson AK. Increased P-wave
dispersion predicts recurrent atrial fibrillation after
cardioversion. J Electrocardiol 2005;38(1):43-6
- 3. Li Z, Hertervig E, Carlson J, Johansson C, Olsson SB, Yuan S
- Dispersion of refractoriness in patients with paroxysmal atrial
fibrillation. Evaluation with simultaneous endocardial
recordings from both atria. J Electrocardiol 2002;35(3):227-34
- 4. Khoury VK, Haluska B, Prins J, Marwick TH. Effects of
glucose-insulin-potassium infusion on chronic ischeamic left
ventricular dysfunction. Heart 2003;89(1):61-5
- 5. Malmberg K, Ryden L, Efendic S. Randomised trial of insulin
glucose infusion followed by subcutaneous insulin treatment in
diabetic patients with acute myocardial infarction (DIGAMI
study): effects on mortality at 1 year. J Am Coll Cardiol
1995;26(1):57-65
- 6. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM,
Andrikopoulos GK, Kyriakidis M, et al. Simple
electrocardiographic markers for the prediction of paroxysmal
idiopathic atrial fibrillation. Am Heart J 1998;135(5 Pt 1):733-8
- 7. Tukek T, Akkaya V, Atilgan D, Demirel E, Oczan M, Guven O,
et al. Effect of left atrial size and function on P-wave dispersion:
a study in patients with paroxysmal atrial fibrillation. Clin
Cardiol 2001;24(10):676-80
- 8. Andrikopolous GK, Dilaveris PE, Richter DJ, Gialafos EJ,
Synetos AG, Gialafos JE. Increased variance of P-wave duration
on the electrocardiogram distinguishes patients with idiopathic
paroxysmal atrial fibrillation. Pacing Clin Electrophysiol
2000;23(7):1127-32
- 9. Tsikouris JP, Kluger J, Song J, White CM. Changes in p-wave
dispersion and p-wave duration after open heart surgery are
associated with the peak incidence of atrial fibrillation. Heart
Lung 2001;30(6):466-71
- 10. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal
A, Aguilar JC, et al. The EuroHeart Failure survey programmea
survey on the quality of care among patients with heart failure
in Europe. Part 1: patient characteristics and diagnosis. Eur
Heart J 2003;24(5):442-63
- 11. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et
al. Temporal relations of atrial fibrillation and congestive heart
failure and their joint influence on mortality: the Framingham
Heart Study. Circulation 2003;107(23):2920-5
- 12. Malmberg K, Rydén L, Hamsten A, Herlitz J, Waldenström A,
Wedel H. Effects of insulin treatment on cause-specific oneyear
mortality and morbidity in diabetic patients with acute
myocardial infarction: DIGAMI Study Group (Diabetes Insulinglucose
in Acute Myocardial Infarction). Eur Heart J
1996;17(9):1337-44
- 13. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H,
Apstein CS. Tight glycemic control in diabetic coronary artery
bypass graft patients improves perioperative outcomes and
decreases recurrent ischemia events. Circulation
2004;109(12):1497-502
- 14. Van der Horst ICC, Zijlstra R, Vant Hof AWJ, Doggen CJM,
de Boer M-J, Suryapranata H, et al. Glucose---insulin---potassium
infusion in patients treated with primary angioplasty for acute
myocardial infarction: the Glucose---Insulin---Potassium Study: a
randomized trial. J Am Coll Cardiol 2003;42(5):784-91
- 15. Bucciarelli-Ducci C, Bianchi M, De Luca L, Battagliese A, Di
Russo C, Proietti P, et al. Effects of glucose---insulin---potassium
infusion on myocardial perfusion and left ventricular
remodeling in patients treated with primary angioplasty for STelevation
acute myocardial infarction. Am J Cardiol
2006;98(10):1349-53
- 16. Rabi D, Clement F, McAlister F, Majumdar S, Sauve R,
Johnson J, et al. Effect of perioperative glucose-insulinpotassium
infusions on mortality and atrial fibrillation after
coronary artery bypass grafting: a systematic review and metaanalysis
- Can J Cardiol 2010;26(6):178-84
- 17. Parsonage W, Hetmanski D, Cowley A. Beneficial
haemodynamic effects of insulin in chronic heart failure. Heart
2001;85(5):508-13
- 18. Xu KY, Zweier JL, Becker LC. Functional coupling between
glycolysis and sarcoplasmic reticulum calcium transport. Circ
Res 1995;77(1):88-97
- 19. Ingemansson MP, Smideberg B, Olsson SB. Intravenous
MgSO4 alone and in combination with glucose, insulin and
potassium (GIK) prolong the atrial cycle length in chronic atrial
fibrillation. Europace 2000;2(2):106-14
- 20. Ingemansson MP, Carlson J, Olsson SB. Modification of
intrinsic AV-nodal properties by magnesium in combination
with glucose, insulin, and potassium (GIK) during chronic atrial
fibrillation. J Electrocardiol 1998;31(4):281-92
- 21. Gal J, Smith A, Riedel B, Royston D.. Preservation and
protection of myocardial function. J Cardiothorac Vasc Anesth
2000;14(3 Suppl 1):22-36
- 22. Oliver M, Opie L. Effects of glucose and fatty acids on
myocardial ischaemia and arrhythmias. Lancet
1994;343(8890):155-8
- 23. Bergstra A, Svilaas T, van den Heuvel AFM, van der Horst
ICC, Zijlstra F. Glucose-insulin-potassium infusion in acute
myocardial infarction: a hemodynamic study. Am Heart J
2006;151(2):345-51.